High-risk neuroblastoma: where do we go?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Reference21 articles.
1. Extended induction chemotherapy does not improve the outcome for high-risk neuroblastoma patients: results of the randomized open-label GPOH trial NB2004-HR;Berthold;Ann Oncol,2020
2. Advances in risk classification and treatment strategies for neuroblastoma;Pinto;J Clin Oncol,2015
3. Treatment and survival of childhood neuroblastoma: evidence from a population-based study in the United States;Coughlan;Pediatr Hematol Oncol,2017
4. A comprehensive safety trial of chimeric antibody 14.18 with GM-CSF, IL-2, and isotretinoin in high-risk neuroblastoma patients following myeloablative therapy: Children’s Oncology Group Study ANBL0931;Ozkaynak;Front Immunol,2018
5. Interleukin-2 with anti-GD2 antibody ch 14.18/CHO (dinutuximab beta) in patients with high-risk neuroblastoma (HR-NBL1/SIOPEN): a multicentre, randomised, phase 3 trial;Ladenstein;Lancet Oncol,2018
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Рersonalized anticancer therapy in pediatric neuroblastoma: clinical aspects;Russian Journal for Personalized Medicine;2023-07-27
2. Suppression of endoplasmic reticulum stress-dependent autophagy enhances cynaropicrin-induced apoptosis via attenuation of the P62/Keap1/Nrf2 pathways in neuroblastoma;Frontiers in Pharmacology;2022-09-16
3. Nanomedicines and cell-based therapies for embryonal tumors of the nervous system;Journal of Controlled Release;2022-08
4. Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma;Pediatric Surgery International;2021-01-04
5. Anti-tumor effect of Huaier extract against neuroblastoma cells in vitro;International Journal of Medical Sciences;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3